Matrix Regenerating Agent (RGTA) in a Neurotrophic Corneal Ulcer

Neurotrophic keratopathy is a condition associated with corneal damage and impaired corneal healing. There are no specific treatments available for this disease and current treatments are not associated with improved visual function. Matrix regenerating agents (RGTA) are recent topical agents showin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Sara, Resende, Rui, Coelho, Pedro, Sampaio, Filipa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688059/
https://www.ncbi.nlm.nih.gov/pubmed/33251074
http://dx.doi.org/10.7759/cureus.11167
Descripción
Sumario:Neurotrophic keratopathy is a condition associated with corneal damage and impaired corneal healing. There are no specific treatments available for this disease and current treatments are not associated with improved visual function. Matrix regenerating agents (RGTA) are recent topical agents showing positive results in the treatment of several corneal conditions, including neurotrophic keratopathy. We report the case of a 73-year-old patient with a neurotrophic ulcer treated with RGTA. Treatment with RGTA allowed complete corneal healing and a dramatic recovery in visual function in our patient. RGTA solutions are an important and safe therapeutic option for the treatment of selected corneal pathology.

Ejemplares similares